Modulation of angiogenesis by thyroid hormone and hormone analogues: implications for cancer management
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modulation of angiogenesis by thyroid hormone and hormone analogues: implications for cancer management
Authors
Keywords
Thyroid hormone, Integrin αvβ3, Angiogenesis inhibition, Cancer chemotherapy
Journal
ANGIOGENESIS
Volume 17, Issue 3, Pages 463-469
Publisher
Springer Nature
Online
2014-01-24
DOI
10.1007/s10456-014-9418-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oroxylin A, a classical natural product, shows a novel inhibitory effect on angiogenesis induced by lipopolysaccharide
- (2014) Xiuming Song et al. Pharmacological Reports
- Angiotensin-converting enzyme and the tumor microenvironment: mechanisms beyond angiogenesis
- (2013) Derick Okwan-Duodu et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Molecular Mechanisms of Actions of Formulations of the Thyroid Hormone Analogue, Tetrac, on the Inflammatory Response
- (2013) Paul J. Davis et al. ENDOCRINE RESEARCH
- Study of the cellular mechanism of Sunitinib mediated inactivation of activated hepatic stellate cells and its implications in angiogenesis
- (2013) Syamantak Majumder et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Vascularity of primary and metastatic renal cell carcinoma specimens
- (2013) Saadia A Aziz et al. Journal of Translational Medicine
- Mouse models for studying angiogenesis and lymphangiogenesis in cancer
- (2013) Lauri Eklund et al. Molecular Oncology
- Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer
- (2013) Dhruba J Bharali et al. Nanomedicine
- Role of CX3CR1 Receptor in Monocyte/Macrophage Driven Neovascularization
- (2013) Arun H. S. Kumar et al. PLoS One
- Lipopolysaccharide Enhances Mouse Lung Tumorigenesis
- (2013) T. Melkamu et al. VETERINARY PATHOLOGY
- Molecular Basis for the Regulation of Angiogenesis by Thrombospondin-1 and -2
- (2013) P. R. Lawler et al. Cold Spring Harbor Perspectives in Medicine
- Response of Human Pancreatic Cancer Cell Xenografts to Tetraiodothyroacetic Acid Nanoparticles
- (2013) Murat Yalcin et al. Hormones & Cancer
- Blocking αvβ3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells
- (2012) Cyntia F. Montenegro et al. BIOCHIMIE
- Assessing the in vivo efficacy of biologic antiangiogenic therapies
- (2012) Peter M. Wilson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Angiopoietins in angiogenesis
- (2012) Ernesta Fagiani et al. CANCER LETTERS
- Insulin-Like Growth Factors Promote Vasculogenesis in Embryonic Stem Cells
- (2012) Stephanie M. Piecewicz et al. PLoS One
- Membrane-bound estrogen receptor-α expression and epidermal growth factor receptor mutation are associated with a poor prognosis in lung adenocarcinoma patients
- (2012) Katsuhiko Shimizu et al. World Journal of Surgical Oncology
- A TLR4-interacting peptide inhibits lipopolysaccharide-stimulated inflammatory responses, migration and invasion of colon cancer SW480 cells
- (2012) Madhusoodhanan Rakhesh et al. OncoImmunology
- Membrane Receptor for Thyroid Hormone: Physiologic and Pharmacologic Implications
- (2011) Paul J. Davis et al. Annual Review of Pharmacology and Toxicology
- Insulin Like Growth Factor-1 (IGF-1) Causes Overproduction of IL-8, an Angiogenic Cytokine and Stimulates Neovascularization in Isoproterenol-Induced Myocardial Infarction in Rats
- (2011) Nagaraja Haleagrahara et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts
- (2011) Shaker A. Mousa et al. LUNG CANCER
- Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: A review
- (2011) Emine Elif Ozkan MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Antiangiogenic therapy: impact on invasion, disease progression and metastasis
- (2011) John M. L. Ebos et al. Nature Reviews Clinical Oncology
- Thyroid hormones and cancer: clinical studies of hypothyroidism in oncology
- (2011) Aleck H Hercbergs et al. Current Opinion in Endocrinology Diabetes and Obesity
- Hypothyroidism in patients with renal cell carcinoma
- (2010) Manuela Schmidinger et al. CANCER
- BB, a new EGFR inhibitor, exhibits prominent anti-angiogenesis and antitumor activities
- (2010) Qi-Ming Sun et al. CANCER BIOLOGY & THERAPY
- Tetraiodothyroacetic Acid (Tetrac) and Nanoparticulate Tetrac Arrest Growth of Medullary Carcinoma of the Thyroid
- (2010) M. Yalcin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Tetraiodothyroacetic Acid and Tetraiodothyroacetic Acid Nanoparticle Effectively Inhibit the Growth of Human Follicular Thyroid Cell Carcinoma
- (2010) Murat Yalcin et al. THYROID
- Hypothyroidism correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib
- (2010) L. M. Riesenbeck et al. WORLD JOURNAL OF UROLOGY
- l-Thyroxine vs. 3,5,3′-triiodo-l-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase
- (2009) Hung-Yun Lin et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Epidermal growth factor released from platelet-rich plasma promotes endothelial cell proliferationin vitro
- (2009) M.-P. Bertrand-Duchesne et al. JOURNAL OF PERIODONTAL RESEARCH
- HIF-1α Modulates Energy Metabolism in Cancer Cells by Inducing Over-Expression of Specific Glycolytic Isoforms
- (2009) Alvaro Marin-Hernandez et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Estrogen and Progesterone Receptor Expression is not Always Specific for Mammary and Gynecologic Carcinomas
- (2009) Shi Wei et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started